Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | Hypertension | UCSD OR UC San Diego OR VA San Diego
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ubenimex;   Other: placebo
2 Recruiting The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan;   Drug: Tadalafil;   Drug: Selexipag
3 Recruiting PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Condition: Portopulmonary Hypertension
Interventions: Drug: Macitentan;   Other: Placebo
4 Recruiting U.S. CTEPH Registry
Conditions: Chronic Thromboembolic Pulmonary Hypertension (CTEPH);   Pulmonary Hypertension
5 Recruiting Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: Bimatoprost sustained-release;   Other: Sham;   Drug: Timolol;   Drug: Timolol Vehicle (placebo)
6 Unknown  24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
Condition: Glaucoma
Intervention: Device: SLT (selective laser trabeculoplasty ) SENSIMED Triggerfish
7 Unknown  24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
Condition: Glaucoma
Intervention: Device: Phacoemulsification with implantation of intraocular lens (CE-IOL) SENSIMED Triggerfish
8 Unknown  Diagnostic Innovations in Glaucoma Study
Condition: Primary Open Angle Glaucoma
9 Unknown  STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk (STARFISH)
Condition: Primary Open Angle Glaucoma

Indicates status has not been verified in more than two years